Baolingbao Biology Co Ltd Strategic Asset Allocation Index
Baolingbao Biology Co Ltd strategic asset allocation index. Baolingbao Biology Co Ltd (002286) has a Strategic Asset Allocation Index of 72.1% as of September 2023. Strategic assets (PP&E of CN¥1.44 Billion plus long-term investments of CN¥-) total CN¥1.44 Billion, measured against net assets of CN¥2.00 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Baolingbao Biology Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Baolingbao Biology Co Ltd (2006–2022)
Strategic asset allocation index of Baolingbao Biology Co Ltd from 2006 to 2022. This chart shows how Baolingbao Biology Co Ltd's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of September 2023, the index stands at 72.1%, representing strategic assets of CN¥1.44 Billion against net assets of CN¥2.00 Billion CNY. Check Baolingbao Biology Co Ltd (002286) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Baolingbao Biology Co Ltd Strategic Asset Allocation Index by Year (2006–2022)
Baolingbao Biology Co Ltd strategic asset allocation index by year from 2006 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Baolingbao Biology Co Ltd from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Baolingbao Biology Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 76.4% | CN¥1.53 Billion | CN¥1.53 Billion | CN¥- | CN¥2.00 Billion | ▲ +5.5 pp |
| 2021 | 70.9% | CN¥1.29 Billion | CN¥1.29 Billion | CN¥- | CN¥1.81 Billion | ▼ -5.6 pp |
| 2020 | 76.6% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥1.60 Billion | ▲ +1.4 pp |
| 2019 | 75.1% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥- | CN¥1.57 Billion | ▼ -19.4 pp |
| 2018 | 94.5% | CN¥1.46 Billion | CN¥1.20 Billion | CN¥256.20 Million | CN¥1.54 Billion | ▲ +15.6 pp |
| 2017 | 78.9% | CN¥1.20 Billion | CN¥1.12 Billion | CN¥87.15 Million | CN¥1.53 Billion | ▲ +2.0 pp |
| 2016 | 76.9% | CN¥1.16 Billion | CN¥1.07 Billion | CN¥86.45 Million | CN¥1.51 Billion | ▼ -0.1 pp |
| 2015 | 77.0% | CN¥1.14 Billion | CN¥1.07 Billion | CN¥67.84 Million | CN¥1.48 Billion | ▲ +13.2 pp |
| 2014 | 63.8% | CN¥924.31 Million | CN¥924.31 Million | CN¥- | CN¥1.45 Billion | ▲ +7.0 pp |
| 2013 | 56.7% | CN¥814.33 Million | CN¥814.33 Million | CN¥- | CN¥1.44 Billion | ▼ -31.3 pp |
| 2012 | 88.1% | CN¥719.99 Million | CN¥719.99 Million | CN¥- | CN¥817.45 Million | ▼ -4.5 pp |
| 2011 | 92.6% | CN¥704.18 Million | CN¥704.18 Million | CN¥- | CN¥760.53 Million | ▲ +5.2 pp |
| 2010 | 87.3% | CN¥614.16 Million | CN¥614.16 Million | CN¥- | CN¥703.11 Million | ▲ +6.2 pp |
| 2009 | 81.2% | CN¥537.74 Million | CN¥537.74 Million | CN¥- | CN¥662.61 Million | ▼ -94.4 pp |
| 2008 | 175.6% | CN¥418.02 Million | CN¥418.02 Million | CN¥- | CN¥238.05 Million | ▼ -13.2 pp |
| 2007 | 188.8% | CN¥364.93 Million | CN¥364.93 Million | CN¥- | CN¥193.28 Million | ▲ +24.2 pp |
| 2006 | 164.6% | CN¥185.20 Million | CN¥185.20 Million | CN¥- | CN¥112.53 Million | — |